Literature DB >> 1805686

Ozone inactivates HIV at noncytotoxic concentrations.

M T Carpendale1, J K Freeberg.   

Abstract

The inactivation of human immunodeficiency virus (HIV) and cytotoxic properties of ozone-treated serum and serum-supplemented media were examined. The titer of HIV suspensions in human serum was reduced in a dose-dependent manner when treated with total reacted ozone concentrations at a range of 0.5 to 3.5 micrograms/ml-1. Complete inactivation of HIV suspensions was achieved by 4.0 micrograms/ml-1 of ozone in the presence or absence of H-9 cells. In contrast, cellular metabolism, as measured by MTT dye cleavage, and DNA replication, as measured by BUdR incorporation, were enhanced in H-9 cells grown in media treated with quantities of ozone that completely inactivate HIV. The permissively HIV-infected cell line HXB/H-9 was cultured in ozone-treated media for six days with culture supernatants being sampled and assayed on alternate days for HIV p24 core protein. HIV p24 was reduced in all treated cultures compared to control cultures, with an average reduction of 46% [p24].

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1805686     DOI: 10.1016/0166-3542(91)90007-e

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  5 in total

1.  Are worry-free transfusions just a whiff of ozone away?

Authors:  A C Baggs
Journal:  CMAJ       Date:  1993-04-01       Impact factor: 8.262

2.  Bactericidal effects of ozone at nonspermicidal concentrations.

Authors:  C Gradil; M D Eaglesome; B Stewart; M M Garcia; F Quimby
Journal:  Can J Vet Res       Date:  1995-07       Impact factor: 1.310

3.  Ozone therapy: A clinical review.

Authors:  A M Elvis; J S Ekta
Journal:  J Nat Sci Biol Med       Date:  2011-01

4.  A reasonable Approach for the Treatment of HIV Infection in the Early Phase with Ozonetherapy (Autohaemotherapy). How 'Inflammatory' Cytokines may have A therapeutic Role.

Authors:  V Bocci
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

5.  Alternative therapies for Covid-19.

Authors:  G Sundararajan; Prince J Isaac; V Andal; R Lakshmipathy
Journal:  Mater Today Proc       Date:  2021-08-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.